日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

1606P Developing a readiness assessment framework for radioligand therapy

1606P 制定放射性配体疗法的准备情况评估框架

Kulke, M H; Ruszniewski, P; Van Cutsem, E; Lombard-Bohas, C; Valle, J W; De Herder, W W; Pavel, M; Degtyarev, E; Brase, J C; Bubuteishvili-Pacaud, L; Voi, M; Salazar, R; Borbath, I; Fazio, N; Smith, D; Capdevila, J; Riechelmann, R P; Yao, J C; Bohra, A; Mous, A; Plucker, E; Merkel, C; Wait, S; Herrmann, K

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

一项随机、开放标签的 II 期研究,旨在评估依维莫司联合帕瑞肽长效制剂或单用依维莫司治疗晚期、高分化、进展性胰腺神经内分泌肿瘤的疗效:COOPERATE-2 试验

Kulke, M H; Ruszniewski, P; Van Cutsem, E; Lombard-Bohas, C; Valle, J W; De Herder, W W; Pavel, M; Degtyarev, E; Brase, J C; Bubuteishvili-Pacaud, L; Voi, M; Salazar, R; Borbath, I; Fazio, N; Smith, D; Capdevila, J; Riechelmann, R P; Yao, J C

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.

循环细胞因子和单核细胞亚群作为舒尼替尼治疗晚期神经内分泌肿瘤患者的疗效和生物活性的生物标志物

Zurita A J, Khajavi M, Wu H-K, Tye L, Huang X, Kulke M H, Lenz H-J, Meropol N J, Carley W, DePrimo S E, Lin E, Wang X, Harmon C S, Heymach J V

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

一项针对晚期类癌和胰腺神经内分泌肿瘤的ganitumab(AMG 479)的多中心、II期开放标签研究

Strosberg, J R; Chan, J A; Ryan, D P; Meyerhardt, J A; Fuchs, C S; Abrams, T; Regan, E; Brady, R; Weber, J; Campos, T; Kvols, L K; Kulke, M H

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer

每周一次的多西他赛、顺铂和伊立替康(TPC)方案:一项针对转移性食管胃癌患者的多中心II期临床试验结果

Enzinger, P C; Ryan, D P; Clark, J W; Muzikansky, A; Earle, C C; Kulke, M H; Meyerhardt, J A; Blaszkowsky, L S; Zhu, A X; Fidias, P; Vincitore, M M; Mayer, R J; Fuchs, C S

Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma

巴雷特食管相关腺癌中10q23(PTEN肿瘤抑制基因位点)的等位基因缺失

Kulke, M H; Odze, R D; Thakore, K S; Thomas, G; Wang, H; Loda, M; Eng, C